| Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550) |
|---|
| 03/05/2008 | EP1893566A1 Cyclohexanesulfonyl derivatives as glyt1 inhibitors to treat schizophrenia |
| 03/05/2008 | EP1893018A1 Fungicidal n-benzyl-5-hydroxy-5-phenylpyrazolines, methods for the production thereof, and agents containing the same |
| 03/05/2008 | EP1732541A4 Cyclic compounds |
| 03/05/2008 | CN101137436A Base stable ionic liquids |
| 03/05/2008 | CN101134698A Application of 1-formamido-3,5-dimethylpyrazole as nitration inhibitor |
| 03/05/2008 | CN101134697A Nitration inhibitor and its application in stabile fertilizer |
| 03/04/2008 | US7338978 Insecticidal anthranilamides |
| 03/04/2008 | US7338972 Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma |
| 03/04/2008 | US7338969 Acyclic, aromatic, heteroaromatic and cyclic ring containing amido-derivatives, useful as antibacterial agent; inhibition of formation of biofilms in personal hygiene articles, toileteries, cosmetics and in industrial settings like ship hulls, food processing systems, oil recovery or paper making plants |
| 03/04/2008 | US7338946 Indazolium trans-[tetrachlorobis(1H-indazol)-ruthenate(III)]; easily water-soluble; exhibits a high effectiveness in the treatment of cancer illnesses |
| 02/28/2008 | WO2008024945A1 Indazole derivatives that inhibit trpv1 and uses thereof |
| 02/28/2008 | WO2008024302A2 Compounds for treating proliferative disorders |
| 02/28/2008 | WO2008023783A1 Amine compound |
| 02/28/2008 | WO2008023235A1 Pyrazole derivatives as anti-platelet and anti-thrombotic agents |
| 02/28/2008 | WO2008023157A1 Nitrogen containing heterocyclic compounds useful as m3-receptor modulators |
| 02/28/2008 | WO2008022777A2 Process for preparing 3-dihalomethylpyrazole-4-carboxylic acid derivatives |
| 02/28/2008 | US20080051446 Heterocyclocarboxamide Derivatives |
| 02/28/2008 | US20080051418 Arylalkanoic Acid Derivative |
| 02/28/2008 | US20080051393 Novel cannabinoids and methods of use |
| 02/28/2008 | US20080051386 Tricyclic Pyrazole Derivatives as Cannabinoid Receptor Modulators |
| 02/28/2008 | DE19822340B4 Thermostabile schwerflüchtige Alkyl-1H-1-pyrazolylmethanamin-Derivate und deren Verwendung als Nitrifikationsinhibitoren Thermostable low volatile alkyl-1H-1-pyrazolylmethanamin derivatives and their use as nitrification inhibitors |
| 02/28/2008 | CA2661898A1 Indazole derivatives that inhibit trpv1 and uses thereof |
| 02/28/2008 | CA2661440A1 Compounds for treating proliferative disorders |
| 02/28/2008 | CA2661407A1 Process for preparing 3-dihalomethylpyrazole-4-carboxylic acid derivatives |
| 02/27/2008 | EP1891028A1 Non-peptidic inhibitors of akap/pka interaction |
| 02/27/2008 | EP1891026A2 Cycloalkylidene compounds as selective estrogen receptor modulators |
| 02/27/2008 | EP1891016A2 Synthesis of 3-amino-4-substituted pyrazole derivatives |
| 02/27/2008 | EP1891015A1 Fungicidal 5-hydroxypyrazolines, method for the production thereof, and agents containing the same |
| 02/27/2008 | EP1248612B1 Novel compounds and compositions as protease inhibitors |
| 02/27/2008 | EP1150959B1 Solid-state form of celecoxib having enhanced bioavailability |
| 02/27/2008 | CN101133052A 1-arylpyrazoles and their use as pesticides |
| 02/27/2008 | CN101133042A Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments |
| 02/27/2008 | CN101133034A Substituted indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds, their preparation and use in medicaments |
| 02/27/2008 | CN101133033A 5-aminopyrazole derivatives as pesticidal compounds |
| 02/27/2008 | CN101133032A Pyrazolylcarboxanilides |
| 02/27/2008 | CN101133031A Method for producing 1-substituted-3-fluoroalkyl pyrazole-4-carboxylate |
| 02/27/2008 | CN101133030A Menthane carboxamide derivatives having cooling properties |
| 02/27/2008 | CN100370975C Inhibitors against the production and releaseof inflammator cytokines |
| 02/26/2008 | US7335780 intermediates for the preparation of crop protection agents; reacting 3-substituted-4,5-dihydro-1H-pyrazole compound with hydrogen halide |
| 02/26/2008 | US7335779 Acyclic, aromatic, heteroaromatic and cyclic ring containing amido-derivatives, useful as antibacterial agent |
| 02/26/2008 | US7335678 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1(VR1) receptor |
| 02/26/2008 | US7335676 Methods for treating inflammatory conditions or inhibiting JNK |
| 02/26/2008 | US7335649 3-{N'-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2-hydroxy-3'-(tetrazol-5-yl)biphenyl for treatment of thrombocytopenia; colony stimulating factors |
| 02/26/2008 | CA2322195C Novel diphenyl-substituted 5-ring-heterocycles, method for producing them and their use as medicaments |
| 02/21/2008 | WO2008021933A2 N-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives as prostaglandine receptor inhibitors |
| 02/21/2008 | WO2008020606A1 Antiangiogenic agent |
| 02/21/2008 | WO2008019968A1 Non-nucleoside reverse transcriptase inhibitors |
| 02/21/2008 | WO2008019690A1 Substituted acetylenic compounds useful for the treatment of diseases |
| 02/21/2008 | WO2008019477A1 Viral polymerase inhibitors |
| 02/21/2008 | WO2007149448A3 Pyrazinones as cellular proliferation inhibitors |
| 02/21/2008 | WO2007141805A3 Novel process for the preparation of sildenafil citrate |
| 02/21/2008 | WO2007123855B1 Pyrazolines for controlling invertebrate pests |
| 02/21/2008 | WO2007103456A3 Piperazine and piperidine biaryl derivatives |
| 02/21/2008 | WO2007010222A3 Therapeutic agents |
| 02/21/2008 | US20080045581 Ppar active compounds |
| 02/21/2008 | US20080045576 Therapeutic n-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives |
| 02/21/2008 | US20080045516 Viral Polymerase Inhibitors |
| 02/21/2008 | US20080045511 3-chloro-5-[6-chloro-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)-phenoxy]-benzonitrile; inhibit HIV reverse transcriptase and are useful for treating Human Immunodeficiency Virus (HIV) mediated diseases |
| 02/21/2008 | US20080045492 Mitotic Kinesin Inhibitors |
| 02/21/2008 | CA2660994A1 Substituted acetylenic compounds useful for the treatment of diseases |
| 02/21/2008 | CA2660555A1 Viral polymerase inhibitors |
| 02/21/2008 | CA2660308A1 Therapeutic n-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives |
| 02/21/2008 | CA2658984A1 Non-nucleoside reverse transcriptase inhibitors |
| 02/20/2008 | EP1889845A1 Novel pleuromutilin derivatives |
| 02/20/2008 | EP1889838A1 Thrombopoietin mimetics |
| 02/20/2008 | EP1888532A1 Heteroaroyl-substituted serine amides |
| 02/20/2008 | EP1675832B1 Heterocyclyl compounds |
| 02/20/2008 | EP1529034B1 Benzoylpyrazolones substituted by 3-aminocarbonyl |
| 02/20/2008 | CN101128435A Pyrazolone compounds as metabotropic glutamate receptor agonists for the treatment of neurological and psychiatric disorders |
| 02/20/2008 | CN101125138A Inhibitors against the production and release of inflammatory cytokines |
| 02/20/2008 | CN100369899C Substituted indazoles with anti-cancer activity |
| 02/19/2008 | US7332608 Potassium channel modulators; cardiovascular disorders; antiarrhythmia agents; synthesis |
| 02/19/2008 | US7332518 Carboxamides as fungicides in agriculture |
| 02/19/2008 | US7332514 Dibenzylamine compound and medicinal use thereof |
| 02/19/2008 | US7332511 Vanilloid receptor ligands and their use in treatments |
| 02/19/2008 | US7332494 Method for treating allergies using substituted pyrazoles |
| 02/19/2008 | US7332481 Thrombopoietin mimetics |
| 02/19/2008 | US7332233 Multilayer; charge generating compound, charge transfer compound; blue phosphorescence |
| 02/19/2008 | US7332149 Diagnosis, therapy of cancer, rheumatoid arthritis, for monitoring therapeutic angiogenesis treatment and destruction of new angiogenic vasculature, imaging tumors, atherosclerosis, restenosis, cardiac ischemia, and myocardial reperfusion injury |
| 02/19/2008 | CA2206366C Substituted 2-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 02/14/2008 | WO2008019302A1 Pyrazolylphenyl and pyrrolylphenyl inhibitors of lta4h for treating inflammation |
| 02/14/2008 | WO2008019292A2 Compositions and methods for potentiating antibiotic activity |
| 02/14/2008 | WO2008018544A1 Sulfonamide compound or salt thereof |
| 02/14/2008 | WO2008017932A2 Heterocycles useful as inhibitors of carbonic anhydrase |
| 02/14/2008 | WO2008017903A1 Positively charged water-soluble prodrugs of aryl- and heteroarylacetic acids with very fast skin penetration rate |
| 02/14/2008 | US20080039510 (1,5-diphenyl-1h-pyrazol-3-yl)oxadiazole derivatives, preparation method thereof and use of same in therapeutics |
| 02/14/2008 | US20080039502 e.g. N-[4-(4'-Methoxy-biphenyl-4-yloxymethyl)-5-methyl-furan-2-carbonyl]-benzenesulfonamide; prostaglandin E4 receptor antagonist; analgesic, antiinflammatory agent; migraines and headache |
| 02/14/2008 | US20080039464 Compounds Which Modulate The CB2 Receptor |
| 02/14/2008 | US20080039442 Compounds With Kv4 Ion Channel Activity |
| 02/14/2008 | US20080039327 3-heterocyclyl-substituted benzoyl derivatives |
| 02/14/2008 | US20080038276 carbamimidoyl benzylamide derivatives; preventing and treating the formation of thrombin during or after a PK dependent disease or condition after fibrinolysis treatment |
| 02/14/2008 | US20080036373 Platinum complex and light-emitting device |
| 02/14/2008 | CA2660424A1 Sulfonamide compound or salt thereof |
| 02/14/2008 | CA2660261A1 Heterocycles useful as inhibitors of carbonic anhydrase |
| 02/13/2008 | EP1885720A2 4-(thiazol-2-ylthioalkyl)-pyrazoles and their use as herbicides |
| 02/13/2008 | EP1885717A1 Shp-2 inhibitors, pharmaceutical compositions comprising them and their use for treating phosphatase-mediated diseases |
| 02/13/2008 | EP1513796B1 Phenyloxyalkanoic acid derivatives as hppar activators |
| 02/13/2008 | EP1480973B1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases |
| 02/13/2008 | CN101124201A Parp抑制剂 Parp inhibitors |
| 02/12/2008 | US7329670 downstream effector of p21ras oncogene; N-(1-(4-Methoxyphenyl)-3-tert-butyl-5-pyrazolyl)-N'-(2,3-dichlorophenyl)urea; antitumor, anticarcinogenic, antiproliferative agent; ras protein signal transduction cascade related cancer |